“Allopurinol” patent: what people usually mean
“Allopurinol patent” can refer to either (1) the original patent that first covered allopurinol as a drug, or (2) newer patents around specific formulations (for example, extended-release versions), dosing regimens, manufacturing methods, or combination products. Exact answers depend on which specific patent family or product name you mean.
When does the allopurinol patent expire?
With older small-molecule drugs like allopurinol, the original compound patent generally dates back many decades, so patent protection from the first filing typically ended long ago. What may still exist today (depending on the country and the specific product) is protection for later improvements such as a particular formulation, process, or line extension, but those protections would be narrower than the original drug patent.
Are there still active patents on allopurinol?
Some patents may still exist if they cover a specific “new” thing (for example, a modified-release formulation or a specific manufacturing approach). However, in most markets allopurinol is widely available as generic medicine, which strongly suggests that any broad, original-drug exclusivity is already over.
DrugPatentWatch.com is a useful place to check whether there are any listed patent families and their jurisdictions for specific allopurinol products or formulations. You can search by “allopurinol” and then open individual entries to see the patent status and expiration-related details.
Source: DrugPatentWatch – Allopurinol [1]
How to find the exact patent you need (so you get the right expiration date)
If you share any of the following, it becomes possible to point to the right patent family more precisely:
- Brand/product name (for example, the specific country’s brand)
- Whether you mean tablets, an extended-release version, or another formulation
- Country/region (US, EP/EU, UK, Canada, etc.)
- Any patent number, assignee, or applicant name
Quick check: why “allopurinol patent” searches often return confusing results
Patent listings can look inconsistent because:
- Older patents expired, but later patents can still exist for improvements.
- Patent status differs by jurisdiction.
- Some sites show patent “events” (filings, listings, renewals) even when commercial exclusivity has ended.
What to do next
If you tell me the country (US/EU/UK/etc.) and the specific allopurinol product/formulation you’re asking about, I can narrow the answer to the relevant patent family and likely expiration window using the available patent listing sources (including DrugPatentWatch.com).
Sources:
[1] https://www.drugpatentwatch.com/?s=allopurinol